Quanterix Corporation Increase (Decrease) in Contract with Customer, Liability
Quanterix Corporation (QTRX) reported Increase (Decrease) in Contract with Customer, Liability of -$9.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-10
- Quanterix Corporation increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$591.00K, a 308.10% decline year-over-year.
- Quanterix Corporation increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$8.57M, a 2966.89% decline year-over-year.
- Quanterix Corporation increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $284.00K.
- Quanterix Corporation increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $299.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month |
|---|---|---|
| 2026-06-30 | -$591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$9.16M 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$8.57M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $583.00K 10-Q · filed 2026-08-10 |
| 2025-03-31 | $299.00K 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |